Maffezzoli, Michele http://orcid.org/0000-0001-7877-8988
Santoni, Matteo
Mazzaschi, Giulia
Rodella, Sara
Lai, Eleonora
Maruzzo, Marco
Basso, Umberto
Bimbatti, Davide
Iacovelli, Roberto
Anghelone, Annunziato
Fiala, Ondřej
Rebuzzi, Sara Elena
Fornarini, Giuseppe
Lolli, Cristian
Massari, Francesco
Rosellini, Matteo
Mollica, Veronica
Nasso, Cecilia
Acunzo, Alessandro
Silini, Enrico Maria
Quaini, Federico
De Filippo, Massimo
Brunelli, Matteo
Banna, Giuseppe L.
Rescigno, Pasquale
Signori, Alessio
Buti, Sebastiano
Funding for this research was provided by:
Università degli Studi di Parma
Article History
Received: 30 September 2023
Accepted: 4 January 2024
First Online: 16 February 2024
Declarations
:
: Dr. Rebuzzi received honoraria as speaker at scientific events and travel accomodation by BMS, Amgen, GSK, Janssen, Astellas, Ipsen, MSD.
: The study was conducted following the approval by the ethics committee of the coordinating Centre (Comitato Etico Regionale delle Marche, ARON-1 study, NCT05287464, date of approval: April 21, 2022) and then by the ethics committee of each participating centre. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: The obtainment of informed consent for live patients was mandatory. Informed consent was obtained from all individual participants included in the study.